WallStreetZenWallStreetZen

NASDAQ: AKTX
Akari Therapeutics PLC Stock Ownership - Who owns Akari Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Akari Therapeutics PLC insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Abizer GaslightwalaCEO2025-08-253,000$0.90
$2.70kBuy
Abizer GaslightwalaCEO2025-08-228,000$0.93
$7.44kBuy
Abizer GaslightwalaCEO2025-08-2110,000$0.94
$9.40kBuy
Abizer GaslightwalaPresident CEO2025-06-245,203$1.16
$6.04kBuy
Abizer GaslightwalaPresident CEO2025-06-23943$1.15
$1.08kBuy
Abizer GaslightwalaPresident CEO2025-06-2010,000$1.20
$12.00kBuy
Abizer GaslightwalaPresident CEO2025-06-1715,000$1.20
$18.00kBuy
Abizer GaslightwalaCEO2025-06-1325,000$1.19
$29.75kBuy
Abizer GaslightwalaCEO2025-06-1220,000$1.23
$24.60kBuy
Abizer GaslightwalaCEO2025-06-1020,000$1.27
$25.40kBuy

1 of 4

AKTX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when AKTX insiders and whales buy or sell their stock.

AKTX Shareholders

What type of owners hold Akari Therapeutics PLC stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Rachelle Suzanne Jacques1.56%1,018,027,792$788.97MInsider
Ray Prudo1.11%722,345,600$559.82MInsider
Stuart Ungar1.11%722,345,600$559.82MInsider
Rpc Pharma Ltd1.11%722,345,600$559.82MInsider
James Hill1.11%722,345,600$559.82MInsider
Hoyoung Huh0.34%223,719,311$173.38MInsider
Wendy F. Dicicco0.24%158,473,915$122.82MInsider
Sandip I. Patel0.19%121,026,008$93.80MInsider
Donald A. Williams0.03%20,000,000$15.50MInsider
Michael Grissinger0.03%20,000,000$15.50MInsider

1 of 3

AKTX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
AKTX0.00%6.84%Net BuyingNet Buying
RADX0.01%0.00%
ACRV54.52%45.48%Net SellingNet Selling
GUTS48.79%51.21%Net Selling
OTLK2.87%97.13%Net Buying
View Top Biotech Stocks

Akari Therapeutics Stock Ownership FAQ

Who owns Akari Therapeutics?

Akari Therapeutics (NASDAQ: AKTX) is owned by 0.00% institutional shareholders, 6.84% Akari Therapeutics insiders, and 93.16% retail investors. Rachelle Suzanne Jacques is the largest individual Akari Therapeutics shareholder, owning 1.02B shares representing 1.56% of the company. Rachelle Suzanne Jacques's Akari Therapeutics shares are currently valued at $768.61M.

If you're new to stock investing, here's how to buy Akari Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.